Evidence map›Paper›PMID 32728355›Full record

ReviewKardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery2020

Stem cells and new intervention measures as emerging therapy in cardiac surgery.

Calogera Pisano, Paolo Nardi, Carmela Rita Balistreri, Claudia Altieri, Fabio Bertoldo, Giovanni Ruvolo

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Calogera PisanoCardiac Surgery Unit, Tor Vergata University Hospital, Rome, Italy.
Paolo NardiCardiac Surgery Unit, Tor Vergata University Hospital, Rome, Italy.
Carmela Rita BalistreriDepartment of Pathobiology and Medical and Forensic Biotechnologies, University of Palermo, Palermo, Italy.
Claudia AltieriCardiac Surgery Unit, Tor Vergata University Hospital, Rome, Italy.
Fabio BertoldoCardiac Surgery Unit, Tor Vergata University Hospital, Rome, Italy.
Giovanni RuvoloCardiac Surgery Unit, Tor Vergata University Hospital, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular disease (CVD) presents a great burden for elderly patients, their caregivers, and health systems. Structural and functional alterations of vessels accumulate throughout life, culminating in increased risk of developing CVD. Several inflammatory pathway are involved in vascular ageing. The growing elderly population worldwide highlights the need to understand how aging promotes CVD in order to develop new strategies to confront this challenge. In this review we analyzed the role of stem cells and new intervention measures as emerging drugs for vascular aging.

Indexed as

agingcardiovascular diseasesinflammationstem cell

Identifiers

PMID32728355
PMCPMC7379210

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.